Next generation sequencing (NGS) has enabled high throughput discovery of somatic mutations. Detection depends on experimental design, lab platforms, parameters and analysis algorithms. However, NGS-based somatic mutation detection is prone to erroneous calls, with reported validation rates near 54 % and congruence between algorithms less than 50%. Here, we developed an algorithm to assign a single statistic, a false discovery rate (FDR), to each somatic mutation identified by NGS. This FDR confidence value accurately discriminates true mutations from erroneous calls. Using sequencing data generated from triplicate exome profiling of C57BL/6 mice and B16-F10 melanoma cells, we used the existing algorithms GATK, SAMtools and SomaticSNiPer to...
Somatic mutations promote the transformation of normal cells to cancer. Accurate identification of s...
Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficu...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Next generation sequencing (NGS) has enabled high throughput discovery of somatic mutations. Detecti...
Next generation sequencing (NGS) has enabled high throughput discovery of somatic mutations. Detecti...
SomaticSeq is an accurate somatic mutation detection pipeline implementing a stochastic boosting alg...
Cancer development and progression is driven by genetic alterations. These alterations include somat...
<div><p>Somatic mutation calling from next-generation sequencing data remains a challenge due to the...
Accumulation of somatic mutations may contribute to the development of cancers and the functional de...
The cost reduction in sequencing and the extensive genomic characterization of a wide variety of can...
Cancer, which affects hundreds of thousands of people worldwide every year and costs billions in tre...
Both single-cell RNA sequencing (scRNA-seq) and DNA sequencing (scDNA-seq) have been applied for cel...
BackgroundA key step in cancer genome analysis is the identification of somatic mutations in the tum...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Next generation sequencing is extensively applied to catalogue somatic mutations in cancer, in resea...
Somatic mutations promote the transformation of normal cells to cancer. Accurate identification of s...
Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficu...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Next generation sequencing (NGS) has enabled high throughput discovery of somatic mutations. Detecti...
Next generation sequencing (NGS) has enabled high throughput discovery of somatic mutations. Detecti...
SomaticSeq is an accurate somatic mutation detection pipeline implementing a stochastic boosting alg...
Cancer development and progression is driven by genetic alterations. These alterations include somat...
<div><p>Somatic mutation calling from next-generation sequencing data remains a challenge due to the...
Accumulation of somatic mutations may contribute to the development of cancers and the functional de...
The cost reduction in sequencing and the extensive genomic characterization of a wide variety of can...
Cancer, which affects hundreds of thousands of people worldwide every year and costs billions in tre...
Both single-cell RNA sequencing (scRNA-seq) and DNA sequencing (scDNA-seq) have been applied for cel...
BackgroundA key step in cancer genome analysis is the identification of somatic mutations in the tum...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Next generation sequencing is extensively applied to catalogue somatic mutations in cancer, in resea...
Somatic mutations promote the transformation of normal cells to cancer. Accurate identification of s...
Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficu...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...